China Resources Medical Holdings Company Limited

HKEX:1515.HK

3.47 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q32012 Q22012 Q12011 Q4
Revenue 4,993.4745,114.0264,695.3553,205.9322,675.3541,772.1231,843.237907.4131,150.381964.9391,143.361916.1171,015.606862.118827.631705.2770.002602.265699.299506.966467.662419.692221.839189.508189.508189.508189.508
Cost of Revenue 4,177.1284,024.7513,994.9992,600.4722,136.3731,377.5491,452.053662.09733.653619.376744.753558.047670.478539.009603.072523.126581.975460.711520.945387.617342.392332.268168.665143.307143.307143.307143.307
Gross Profit 816.3461,089.275700.356605.46538.981394.574391.184245.323416.728345.563398.608358.07345.128323.109224.559182.074188.027141.554178.354119.349125.2787.42453.17446.20146.20146.20146.201
Gross Profit Ratio 0.1630.2130.1490.1890.2010.2230.2120.270.3620.3580.3490.3910.340.3750.2710.2580.2440.2350.2550.2350.2680.2080.240.2440.2440.2440.244
Reseach & Development Expenses 000000000000000000000000000
General & Administrative Expenses 522.744448.025496.228312.433278.943188.692212.33106.803127.189107.008110.07193.471108.31178.2494.35953.57596.26643.0542.85334.51840.67525.10716.44610.87510.87510.87510.875
Selling & Marketing Expenses 2.555.27810.7538.7798.6378.1458.3216.2649.176.96510.9238.96515.8919.22113.75210.3762.3838.2223.0335.1813.6044.7472.0881.6031.6031.6031.603
SG&A 595.585457.621539.532324.744369.842196.034245.33113.067139.596113.973120.994102.436124.20287.461108.11163.95198.64951.27245.88639.69944.27929.85418.53312.47812.47812.47812.478
Other Expenses 00000000000000000000-0.219-0.113-0.113-0.038-0.038-0.038-0.038
Operating Expenses 922.93464.112597.798325.775570.691156.396171.846112.005154.853115.214120.616108.16213.84952.3211,851.15146.256101.08829.0888.60921.47535.3959.73918.42112.44112.44112.44112.441
Operating Income 220.55631.69168.588281.01169.139198.54145.854132.256277.132231.59277.614255.634220.926235.648116.448118.12389.37890.282132.46879.6580.99157.5743.0137.99737.99737.99737.997
Operating Income Ratio 0.0440.1240.0360.0880.0630.1120.0790.1460.2410.240.2430.2790.2180.2730.1410.1680.1160.150.1890.1570.1730.1370.1940.2010.2010.2010.201
Total Other Income Expenses Net -352.755-6.564-59.60832.951-168.80671.602116.1423.93510.22622.35131.40824.287-58.988161.921-1,723.39136.33920.53447.77468.91635.725-8.14312.591-7.258-1.178-1.178-1.178-1.178
Income Before Tax -132.205625.126108.98313.9610.333270.142261.994156.191287.358253.941309.022279.921161.938397.569-1,606.943154.462109.912138.056201.384115.37572.84870.16135.75236.8236.8236.8236.82
Income Before Tax Ratio -0.0260.1220.0230.09800.1520.1420.1720.250.2630.270.3060.1590.461-1.9420.2190.1430.2290.2880.2280.1560.1670.1610.1940.1940.1940.194
Income Tax Expense 26.773138.25851.29543.365220.20664.81751.89345.97175.24865.41776.11373.27463.26666.54627.79419.53741.71633.83846.95830.27229.1217.74511.7169.1369.1369.1369.136
Net Income -139.997397.67721.186244.669218.6199.315202.378107.753207.744183.121228.908201.9996.11324.924-1,637.276130.31265.419101.626147.66782.38439.63850.35424.03627.68427.68427.68427.684
Net Income Ratio -0.0280.0780.0050.0760.0820.1120.110.1190.1810.190.20.220.0950.377-1.9780.1850.0850.1690.2110.1630.0850.120.1080.1460.1460.1460.146
EPS -0.110.310.0170.190.170.160.160.0860.160.150.180.160.0750.25-1.670.160.0760.120.180.0990.0620.0990.0420.0330.0330.0330.033
EPS Diluted -0.110.310.0170.190.170.160.160.0860.160.150.180.160.0750.25-1.670.160.080.120.180.0990.0620.0990.0420.0330.0330.0330.033
EBITDA 519.056892.294436.92445.821270.983256.924199.305173.274303.966262.489316.146286.715254.96264.961140.847141.365111.309109.613150.81197.10296.62274.98152.13747.03847.03847.03847.038
EBITDA Ratio 0.1040.1740.0930.1390.1010.1450.1080.1910.2640.2720.2770.3130.2510.3070.170.20.1450.1820.2160.1920.2070.1790.2350.2480.2480.2480.248